A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2011
10/26/2011	CN102225923A Method for preparing dihydromyricetin from Ampelopsis grossedentata
10/26/2011	CN102225913A Rheinic acid derivatives and treatment application thereof
10/26/2011	CN102225203A Pharmaceutical composition used for lowering blood pressure
10/26/2011	CN102225201A New application of glycolytic inhibitor
10/26/2011	CN102225176A Chinese medicine composition for treating haemorrhoids
10/26/2011	CN102225174A Application of pharmaceutical composition in preparation of medicine for treating coronary cardiopathy
10/26/2011	CN102225140A Plaster for treating stroke hemiplegia
10/26/2011	CN102225132A Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof
10/26/2011	CN102225128A Tibetan medicine composite and application thereof in preparation of medicine for resisting heart cerebrovascular diseases and neurologic diseases
10/26/2011	CN102225126A Traditional Chinese medicine granule for preventing and treating non-hemorrhagic cerebral infarction
10/26/2011	CN102225122A Caffeine-free tea polyphenol and preparation method thereof
10/26/2011	CN102225107A Yixin xuezhikang capsule
10/26/2011	CN102225106A Propolis wine with berchemia lineate and preparation method thereof
10/26/2011	CN102225104A Traditional Chinese and western medicine formula for treating hemorrhoid
10/26/2011	CN102225101A Traditional Chinese medicine for treating hemorrhoids
10/26/2011	CN102225100A Chinese medicinal formulation for treating cardiovascular and cerebrovascular diseases and preparation process of products thereof
10/26/2011	CN102225099A Chinese medicinal composition orally and externally used for treating hemorrhoid
10/26/2011	CN102225095A Effective fraction of plantain seeds as well as preparation method and application thereof
10/26/2011	CN102225088A Application of Eucommia lignans in preparing medicaments for preventing and treating hypertension-induced renal injury
10/26/2011	CN102225087A Xanthophyll compound preparation with powerful eye-protecting effect
10/26/2011	CN102225084A Processing process of Chinese medicinal decoction pieces of dogbane leaves
10/26/2011	CN102225083A Pharmaceutical composition and application thereof
10/26/2011	CN102225079A Medicament used for treating thromboangitis obliterans
10/26/2011	CN102225076A Modified Maixuekang preparation, modified Maixuekang enteric-coated preparation as well as preparation methods and applications thereof
10/26/2011	CN102225048A Curcumin compound injection and intravenous injection preparation thereof
10/26/2011	CN102224968A Rumex beverage and preparation method thereof
10/26/2011	CN101966221B Application of prickly pear in preparation of medicaments or health-care products
10/26/2011	CN101961393B Chinese medicinal composition for treating haemorrhoids and preparation method thereof
10/26/2011	CN101919882B Application of red yeast rice to preparing abdominal aneurvsm medicine
10/26/2011	CN101780218B Medicinal lotion for treating haemorrhoids
10/26/2011	CN101757449B Ointment preparation for treating hemorrhoid
10/26/2011	CN101757129B Composition preparation containing orientin and isoorientin and preparation method thereof
10/26/2011	CN101711853B Traditional Chinese medicine composition for treating symptoms of bradycardia and preparation method thereof
10/26/2011	CN101676266B Deuterium-substituted omega-diphenylurea and its derivatives, as well as pharmaceutical composition containing the same
10/26/2011	CN101642479B Pseudo-ginseng effective component R, pharmaceutical composition thereof, preparation and usage thereof
10/26/2011	CN101632732B Medicine for treating cerebrovascular diseases
10/26/2011	CN101564423B Medicament for treating cardiovascular and cerebrovascular diseases and preparation method thereof
10/26/2011	CN101525598B Method for purifying human urinary trypsin inhibitor
10/26/2011	CN101411735B Quality control method of pharmaceutical composition for preventing and treating coronary heart disease
10/26/2011	CN101411732B Hypericuin perforatum L. extract as well as preparation method and application thereof
10/26/2011	CN101342274B Curculigo orchioides extract, preparation method and uses thereof
10/26/2011	CN101293003B Effect section of frangrant ainsliaea herb, preparation method and application thereof
10/26/2011	CN101204216B Coffee partner containing octacosanol and manufacture method thereof
10/26/2011	CN101085227B Composition for treating angitis, preparation and its preparation method
10/26/2011	CN101084998B Compound red sage root freezing-dried powder injection
10/26/2011	CN101048166B Abnormal protein removing composition
10/25/2011	US8044182 Adiponectin and uses thereof
10/25/2011	US8044070 Heteroaryloxy nitrogenous saturated heterocyclic derivative
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011	US8044025 Urocortin proteins and uses thereof
10/25/2011	US8044018 Reagents and methods for smooth muscle therapies
10/25/2011	US8043855 vector contains an adenoviral genome from which the open reading frames E1 and/or E3 have been deleted, but retains enough sequence to make it able to replicate in vitro; also contains a DNA sequence regulated by promoters that encode for fibrosis treatment proteins
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	US8043624 Compositions and methods for treatment of microbial infections
10/25/2011	CA2657355C Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
10/25/2011	CA2581225C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/25/2011	CA2399865C Novel scavenger receptor
10/20/2011	WO2011130740A2 Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use
10/20/2011	WO2011130537A2 Pharmaceutical compositions and methods for digesting atherosclerotic plaques
10/20/2011	WO2011129680A1 A use of an effective amount of a composition comprising o. stamineus leaf extract
10/20/2011	WO2011129516A1 Decursinol derivative, a production method for the same and a pharmaceutical composition comprising the same
10/20/2011	WO2011129457A1 Pharmaceutical composition for treating macular edema
10/20/2011	WO2011129424A1 Pharmaceutical agent for prevention and/or treatment of htlv-1-associated myelopathy
10/20/2011	WO2011128420A1 Pyridyl-vinyl pyrazoloquinolines as par1 inhibitors
10/20/2011	WO2011128265A1 Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e] azulenes as vasopressin antagonists
10/20/2011	WO2011127829A1 Use of carbon nanoparticles as externl applied medicament for treating hemorrhoid
10/20/2011	WO2011127625A1 Method for regulating microrna content in organisms and uses thereof
10/20/2011	WO2011066417A3 Antibodies and conjugates for modulators of angiogenesis
10/20/2011	WO2011052940A3 Process for preparing clopidogrel hydrogensulfate form i
10/20/2011	WO2011038157A3 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins
10/20/2011	US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011	US20110258712 Myostatin isoform
10/20/2011	US20110257623 Implantable medical devices having microporous surface layers and method for reducing foreign body response to the same
10/20/2011	US20110257259 Nut skin products and methods of use thereof
10/20/2011	US20110257252 Novel antithrombotic diadenosine tetraphosphates and related analogs
10/20/2011	US20110257246 RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
10/20/2011	US20110257239 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
10/20/2011	US20110257238 Heteroaryl Dihydroindolones as Kinase Inhibitors
10/20/2011	US20110257232 Biphenyl oxadiazole derivatives as sphingosine-1-phosphate receptors modulators
10/20/2011	US20110257227 Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
10/20/2011	US20110257222 Compounds and methods for the treatment of pain and other diseases
10/20/2011	US20110257214 Morphinan compounds
10/20/2011	US20110257208 Compounds useful as faah modulators and uses thereof
10/20/2011	US20110257198 Piperidine derivatives useful as orexin antagonists
10/20/2011	US20110257194 Substituted oxindol derivatives and medicaments containing the same
10/20/2011	US20110257190 Crystalline forms
10/20/2011	US20110257179 Novel thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011	US20110257178 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/20/2011	US20110257176 Nitrogen heterocycle derivatives as proteasome modulators
10/20/2011	US20110257171 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
10/20/2011	US20110257170 4-morpholino-pyrido[3,2-d]pyrimidines
10/20/2011	US20110257164 Dipeptidyl peptidase iv inhibitors
10/20/2011	US20110257161 Novel diaza-bicyclononyl-phenyl derivatives and their medical use
10/20/2011	US20110257153 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/20/2011	US20110257149 Formulation for oral transmucosal administration of lipid-lowering drugs
10/20/2011	US20110257145 Method of treating neurological diseases
10/20/2011	US20110257140 Biomarkers of Mineralocorticoid Receptor Activation
10/20/2011	US20110257132 Charged phospholipid compositions and methods for their use
10/20/2011	US20110257130 Compositions and Methods for Treatment of Renin-Angiotensin Aldosterone System (RAAS)- Related Disorders
10/20/2011	US20110257127 A2b adenosine receptor antagonists

1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 1595